Kasper Burkhard S
Epilepsy Center, Department of Neurology, Friedrich-Alexander University Erlangen-Nuremberg Germany.
Free Neuropathol. 2021 Apr 23;2:11. doi: 10.17879/freeneuropathology-2021-3324. eCollection 2021 Jan.
50 years ago back in 1971, David C. Taylor and colleagues from England reported on a small series of surgical epilepsy cases proposing a new type of tissue lesion as a cause of difficult-to-treat focal epilepsy: a localized malformation of cerebral cortex. The lesion is now known as focal cortical dysplasia (FCD) Type II or Taylor's cortical dysplasia. FCD II is not rare, and today is a frequent finding in neurosurgical epilepsy specimens. Medical progress has been achieved in that the majority of FCD II is diagnosed non-invasively by magnetic resonance imaging today. Detailed studies on FCD revealed that the lesion belongs to a spectrum of mTOR-o-pathies, thereby confirming the authors´ initial hypothesis of a relationship to tuberous sclerosis. Here, selected original materials from Taylor´s series are presented as virtual slides, supplemented by original clinical records, in order to give a first-hand impression of this milestone finding in neuropathology of epilepsy.
50年前,也就是1971年,来自英国的大卫·C·泰勒及其同事报告了一小系列外科癫痫病例,提出一种新型组织病变是难治性局灶性癫痫的病因:一种局限性大脑皮质畸形。这种病变现在被称为II型局灶性皮质发育不良(FCD)或泰勒皮质发育不良。FCD II并不罕见,如今在神经外科癫痫标本中经常能发现。医学已经取得了进展,因为如今大多数FCD II是通过磁共振成像进行无创诊断的。对FCD的详细研究表明,该病变属于mTOR通路病谱,从而证实了作者最初关于与结节性硬化症有关的假设。在此,泰勒系列中的部分原始材料以虚拟切片的形式呈现,并辅以原始临床记录,以便让人们对癫痫神经病理学这一里程碑式的发现有第一手的认识。